Search Results - "Abtahi, Dean"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection by Bennett, Richard L., Blalock, William L., Abtahi, Dean M., Pan, Yu, Moyer, Sue A., May, W. Stratford

    Published in Blood (01-08-2006)
    “…While the interferon (IFN)–inducible double-stranded RNA (dsRNA)–dependent protein kinase PKR is reported to initiate apoptosis in some instances, the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Targeting Src- Family Kinase Activation and Downstream Molecular Events To Overcome MM Cell Growth, Survival, and Drug- Resistance by Podar, Klaus, Tai, Yu-Tzu, Abtahi, Dean, Raab, Marc S., Yasui, Hiroshi, Ishitsuka, Kenji, Shiraishi, Norihiko, Catley, Laurence P., Sattler, Martin, Raje, Noopur, Hideshima, Teru, Chauhan, Dharminder

    Published in Blood (16-11-2005)
    “…IL-6 induces growth and survival factor in multiple myeloma (MM) via ERK and Akt signaling cascades. Our recent studies difined early signaling events…”
    Get full text
    Journal Article
  4. 4

    The PKC- Inhibitor Enzastaurin Inhibits MM Cell Growth, Survival and Migration in the Bone Marrow Microenvironment by Podar, Klaus, Raab, Marc S., Abtahi, Dean, Tai, Yu-Tzu, Lin, Boris, Munshi, Nikhil C., Hideshima, Teru, Chauhan, Dharminder, Anderson, Kenneth C.

    Published in Blood (16-11-2005)
    “…Members of the protein kinase C (PKC) family of serine- threonine protein kinases mediate multiple physiological functions including differentiation, growth…”
    Get full text
    Journal Article
  5. 5

    Up-Regulation of c-Jun contributes to the Induction of Apoptosis by Adaphostin in Human Multiple Myeloma Cells by Podar, Klaus, Tonon, Giovanni, Raab, Marc S., Sattler, Martin, Abtahi, Dean, Tai, Yu-Tzu, LeGouill, Steven, Ishitsuka, Kenji, Yasui, Hiroshi, Depinho, Ron A., Hideshima, Teru, Chauhan, Dharminder, Anderson, Kenneth C.

    Published in Blood (16-11-2005)
    “…Adaphostin (NCI, Bethesda, MD) has been examined as an alternative to the 2-phenylaminopyrimidine derivate imatinib mesylate, with remarkable efficacy in the…”
    Get full text
    Journal Article